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service provider
knowledge

BANGLADESH
Recommendations
• Train and update service
providers from all levels
of the health system on
broader MNH issues, particularly PE/E.
• Available PE/E management protocol at facilities.

KNOWLEDGE AND PRACTICES FOR PRE-ECLAMPSIA
AND ECLAMPSIA CARE
Pre-eclampsia is a leading cause of maternal and newborn morbidity and mortality worldwide. In Bangladesh, it is the second most common direct cause of
maternal deaths. The Bangladesh Maternal Mortality Survey revealed that 20
percent - between 1,000 and 1,200 maternal deaths - are from pre-eclampsia
and eclampsia (PE/E) each year.
Early detection and treatment during antenatal care (ANC) visits are instrumental in reducing deaths from PE/E. In Bangladesh, however, primary health care
(PHC) providers have limited knowledge of the condition, and in many cases are
unaware of how to detect, manage, and treat it. This knowledge gap contributes
to the high prevalence of PE/E-related deaths.

RESEARCH

AUGUST 2017

This research brief presents the findings of a landscape analysis that was conducted to better understand service providers’ maternal health knowledge, attitudes, and practices, particularly around PE/E.
Population Council researchers, in four districts and 12 upazilas, interviewed
289 service providers from 134 facilities. Among these service providers 79
were doctors, including those working in the maternal and child health unit. Researchers interviewed 210 other providers, which included family welfare visitors
(FWV), sub-assistant community medical officers (SACMO), nurses, and medical
assistants.
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• Organize competency
based training for all PHC
providers, with a refresher training after three
months.
• Screen every patient in
antenatal, delivery, and
postnatal for increased
blood pressure and assess for PE/E risk.
• Review and revise curricula to include PE/E for
nurses, midwives, FWVs,
SACMOs and other paramedics.
• Providers should know of
the antihypertensive and
anticonvulsant drugs.
• A checklist can be used in
facilities to assess PE/E
risk and initiate prevention using calcium and
aspirin.
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FINDINGS

Knowledge, attitudes, and practices for use of MgSO4

Service provider knowledge on detecting hypertension

Service providers were asked to demonstrate their knowledge of the loading and maintenance doses of MgSO4 according to the Pritchard Regimen. Findings suggest that
35 percent of doctors and 1 percent of other providers
know the correct loading dose of MgSO4 to be administered, and 36 percent of doctors and 1 percent of other
service providers know the correct maintenance doses.

Eighty-four percent of doctors and 79 percent of other
providers can correctly define hypertension as systolic
blood pressure of ≥140 mmHg and/or diastolic blood
pressure of ≥90 mmHg. Seventeen percent of doctors
and 22 percent of service providers are confused about
the definition of hypertension.
All service providers were requested to identify signs and
symptoms of pre-eclampsia, severe pre-eclampsia, and
eclampsia. Results show that doctors have a strong understanding and other service providers had reasonably
good knowledge of the signs and symptoms of PE, severe PE and eclampsia, including upper abdominal pain,
headache, and blurred vision. They also mentioned some
less important signs and symptoms, such as weight gain
and oedema.
Knowledge and practice for PE prevention
Researchers assessed service provider’s knowledge of
risk factors of pre-eclampsia, including history of hypertension, diabetes, extreme maternal age (<20 or >35
years). Only 1.87 percent of providers observed in primary and secondary facilities looked for pre-eclampsia risk
factors during antenatal care visits.

Although rare, toxicity of MgSO4 may occur, in which case
calcium gluconate is the antidote. All service providers
were asked if they knew of any drug used to treat toxicity,
and only 30 percent of doctors and less than 1 percent of
other providers know calcium gluconate as the remedy.
Provider use of MgSO4
Researchers asked service providers about their current
use of MgSO4, its supply and availability at facilities, alternative drugs used to control seizures, and barriers to
MgSO4 use. Only 37 percent of doctors and 4 percent of
other providers reported they currently use MgSO4. Thirty
three percent of providers reported sufficient supply, 5
percent overall reported inadequate supply, and the remaining 62 percent of providers reported none.

Researchers investigated service provider knowledge on
prophylactic drugs, such as calcium supplements or lowdose aspirin, and found only 6 percent of doctors and no
other providers are aware of the use of aspirin supplements to prevent pre-eclampsia.

About 71 percent of doctors and 35 percent of other service providers mentioned some barriers to administering
the loading dose of MgSO4 to severe PE/E patients at primary facilities. Those barriers included the lack of training, lack of knowledge of side effects, lack of equipment
or supplies, need for doctor supervision, fear of community reaction if patients were to die after use of MgSO4
and lack of proper monitoring.

No providers mentioned calcium supplements as prophylaxis, most likely because the drug is already regularly
given during ANC. About 20 percent of doctors and 3 percent of other providers mentioned other drugs as prophylaxis, or said that they did not know of any prophylactic
drugs, indicating confusion about prevention measures.

About 39 percent of doctors and 4 percent of other providers use alternative drugs - diazepam and phenytoin - for
controlling convulsions. Among those who reported using
alternative drugs, 58 percent of doctors and 63 percent
of other providers use an appropriate, though less safe
and effective, alternative like diazepam.

Knowledge and practices for managing PE/E

Providers must be given more autonomy if they are to
reduce PE/E-related deaths. With stronger knowledge of
detection, prevention and management using antihypertensive drugs and MgSO4, providers at all levels of the
health system can save the lives of women and babies.

Researchers asked about commonly used antihypertensive drugs for managing mild, moderate, and severe hypertension in pregnancy. They also questioned providers
about the appropriate blood pressure levels for administration of antihypertensive drugs.
About 77 percent of doctors and 19 percent of other service providers mentioned methyldopa or nifedipine as the
drugs of choice for managing mild to moderate hypertension. Only 9 percent of doctors, and no other providers,
mentioned hydralazine to manage hypertension.
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